Hot Sale for Vitamin A Deficiency Treatment - Dihydroartemisinin Tabs – KeMing Medicines Detail:
FOB Price | Inquiry |
Min.Order Quantity | 1,000,000 tablets |
Supply Ability | 120,000,000 tablets/Month |
Port | Shanghai |
Payment Terms | T/T in advance |
Product Detail | |
Product name | Dihydroartemisinin Tabs |
Specification | 60mg |
Description | A white film-coated tablet |
Standard | CP |
Package | 8’s/blister/box |
Transportation | Ocean,Land,Air |
Certificate | GMP |
Price | Inquiry |
Quality guaranteeperiod | for 36 months |
Product Description | [Pharmacology] Powerful plasmodicide of malaria parasite agamete which quickly controls symptoms. Highly effective against all forms of malaria including multi_drug resistant malaria. It has high safety and low toxicity.Reproduction toxicology,increase fetal absorption during pregnancy in mice.No mutation effect observed. 60mg for the following 4 or 6 days.See tablet below for children. |
Product detail pictures:
Related Product Guide:
Medication & Dietary Supplement Interactions – What You Should Know about Drugs and Vitamins
Cholesterol Drugs and Low Vitamin D Along With Other Hormone Levels
Our corporation puts emphasis about the administration, the introduction of talented staff, plus the construction of team building, attempting hard to improve the quality and liability consciousness of team members. Our organization successfully attained IS9001 Certification and European CE Certification of Hot Sale for Vitamin A Deficiency Treatment - Dihydroartemisinin Tabs – KeMing Medicines, The product will supply to all over the world, such as: Austria, moldova, Lisbon, we rely on own advantages to build a mutual-benefit commerce mechanism with our cooperative partners. As a result, we have gained a global sales network reaching the Middle East, Turkey, Malaysia and Vietnamese.
By Meredith from St. Petersburg - 2017.11.20 15:58
In China, we have many partners, this company is the most satisfying to us, reliable quality and good credit, it is worth appreciation.
By Mavis from UK - 2017.12.31 14:53